It was found that the expression of BCL9 was significantly increased in HCC specimens, especially in bone metastatic specimens, as compared with that in the normal liver specimens (34.4% and 90.3% vs. 0.00%, P = 0.00). Here, BCL9 is linked to hepatocellular carcinoma.